查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1197438

碎石機市場——增長、趨勢、COVID-19 的影響和預測 (2023-2028)

Lithotripsy Device Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2021 年全球碎石設備市場價值 16.7 億美元，預計到 2027 年將達到 20.3 億美元，在 2022-2027 年的預測期內以 5.5% 的複合年增長率增長。

這個市場主要是由技術進步、尿路結石發病率增加、體外衝擊波碎石術發病率增加以及意識提高推動的。 COVID-19 的爆發嚴重影響了碎石術市場。 麻醉師需要管理感染 COVID-19 的患者，這迫使他們放棄擇期手術。 擇期手術不得不取消，因為需要一名麻醉師來管理感染 COVID-19 的患者。 我們不得不減少用於泌尿科患者的床位數量，以便為我們新的 COVID-19 病房騰出專用床位和工作人員。 我們還需要確保醫院污染不會感染擇期手術患者。 最重要的是，從泌尿科的角度來看，大部分剩餘的泌尿科醫務人員現在都完全致力於管理新 COVID-19 病房中的感染患者。 因此，不斷增長的 COVID-19 患者群體和擇期手術的減少對 2020 年的市場產生了影響。

尿石症是一種常見的泌尿系統疾病，給全世界的醫療保健系統帶來了沉重的負擔。 這與終末期腎病風險增加有關，推動了對碎石設備的需求。 根據歐洲泌尿外科協會的數據，2019 年尿路結石的患病率從 1% 到 20% 不等。 生活水平高的國家，如加拿大、瑞典和美國，腎結石的患病率明顯更高（>10%）。 在過去的二十年裡，一些地區報告說增長了 37% 或更多。 腎結石與終末期腎病的風險有關。 隨著世界範圍內尿石症的增加，需要一種安全、有效且廉價的尿石症治療方法。

多年來，碎石術一直是治療腎結石的首選方法。 其主要原因是其相對安全、成本低、恢復時間短和患者預後良好。 因此，所有這些因素都在推動市場的增長。

然而，除了一些好處外，碎石療法也存在一些風險。 這種治療有時會導致內出血，可能需要輸血。 副作用是腎臟受損，因為小結石顆粒會阻塞尿液。 還有高血壓等並發症，也在製約市場。 此外，碎石沖擊波的副作用往往會導致高血壓、糖尿病，在某些情況下還會導致腎功能永久喪失，這對碎石市場構成了重大障礙。

碎石機市場趨勢

體外衝擊波碎石機 (ESWL) 細分市場預計將佔據較大的市場份額

體外衝擊波碎石術是一種治療腎結石和輸尿管結石的非手術方法。 一股高能衝擊波穿過身體，將石頭打碎成沙粒般的細小顆粒。 體外衝擊波碎石術 (ESWL) 用於治療腎結石和輸尿管結石。 該技術正在被世界各地的醫生使用，預計在未來幾年將變得更加流行，因為它具有微創、減輕疼痛、縮短住院時間和加快恢復時間等優勢。

隨著 COVID-19 病例的增加，泌尿外科手術的數量正在減少，體外衝擊波碎石機 (ESWL) 的數量也在這段時間減少，這將對市場產生輕微的負面影響。

這是最常見的體外碎石術。 在體外衝擊波碎石術 (ESWL) 中，一種稱為溶菌碎石機的特殊機器會產生高能衝擊波，例如聲波、X 射線或超聲波，這些衝擊波穿過身體直至擊中腎結石。

ESWL 最早在美國實施。 然而，據報導一些患者在 ESWL 治療後不成功。 ESWL 僅用於某些腎結石和輸尿管結石。 因此，它並不適用於所有石材類型和場地。 該過程通常被認為是安全和快速的，因為它只需要 45 分鐘。 對非侵入性程序不斷增長的需求導致了 ESWL 的採用。

因此，再加上腎臟相關疾病的增加和全球意識的提高，很可能會在預測期內推動市場增長。

北美在碎石機市場份額最大

在北美，碎石術市場預計將在預測期內增長。 據估計，慢性腎病在女性中比在男性中更常見。 眾所周知，全世界患有慢性腎病的患者人數正在增加。 美國腎病統計數據傳達了慢性腎病 (CKD) 和終末期腎病 (ESRD) 的負擔。

COVID-19 大流行對碎石市場產生了負面影響，因為手術數量減少導致碎石設備的使用減少。 大流行還擾亂了供應鍊和市場，對企業和金融市場產生了負面影響，從而直接影響了生產和需求。

根據美國疾病控制和預防中心的數據，2019 年，估計約有 3700 萬人（即成年人口的七分之一，即 15%）將患有慢性腎病。 隨著腎病病例的增加，美國每年完成超過 50,000 例碎石手術，推動了碎石市場的發展。

2019 年 1 月，Shockwave Medical 開始了一項冠狀動脈碎石術設備的關鍵美國臨床試驗，該設備旨在為嚴重鈣化的冠狀動脈病變準備支架置入術。 該技術利用聲波壓力波在不損傷動脈組織的情況下打碎內膜和內側鈣，預計將擴大公司業務並幫助推動該國的碎石機市場。

因此，由於美國腎結石病的高患病率和高治療率，該地區在全球市場的份額預計在預測期內將顯著增長。 此外，產品發布、收購、聯合研究等預計將推動該地區的市場。

碎石設備市場競爭者分析

碎石術市場是一個競爭激烈的市場。 碎石設備的主要市場參與者包括 EDAP TMS、波士頓科學公司、奧林巴斯公司、Accuron、DirexGroup 等。 每家公司都採取了某些戰略舉措，例如合併、新產品發布、收購和合作夥伴關係，以幫助鞏固其市場地位。 此外，公司還專注於增加碎石設備的應用，以鞏固其在預測期內的地位。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章研究方法論

第 3 章執行摘要

第4章市場動態

  • 市場概覽
  • 市場驅動力
    • 增加尿石症的負擔
    • 增加體外衝擊波碎石術的數量
    • 微創手術的技術進步
  • 市場製約因素
    • 與碎石術相關的副作用
    • 去除結石的替代療法的可用性
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模:百萬美元）

  • 按類型
    • 體外衝擊波碎石裝置
    • 體石破碎機
      • 激光碎石設備
      • 電液碎石機
      • 超聲波碎石機
      • 氣動（彈道）碎石機
  • 通過申請
    • 腎結石
    • 輸尿管結石
    • 胰腺結石
    • 膽管結石
  • 最終用戶
    • 醫院
    • 門診手術中心
    • 其他最終用戶
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章競爭格局

  • 公司簡介
    • EDAP TMS
    • Electro Medical Systems SA（Boston Scientific Corporation）
    • Olympus Americas
    • Dornier MedTech
    • Becton, Dickinson, and Company
    • Storz Medical AG
    • Cook Medical LLC
    • Walz Elektronik GmbH
    • Novamedtek
    • Elmed Medical Systems
    • Karl Storz SE & Co. KG
    • Siemens Healthineers AG
    • Richard Wolf GmbH
    • DirexGroup
    • Lumenis

第7章 市場機會與今後動向

簡介目錄
Product Code: 64420

The global lithotripsy device market was valued at USD 1.67 billion in 2021, and it is expected to reach USD 2.03 billion by 2027, registering a CAGR of 5.5% during the forecast period 2022-2027.

The market is primarily driven by the increasing incidence of urolithiasis, a rise in the number of extracorporeal shock waves lithotripsy procedures, and technological advancements coupled with rising awareness. The COVID-19 pandemic has severely impacted the lithotripsy devices market, as anesthesiologists were needed to manage patients infected with COVID-19 and, therefore, had to withdraw from elective surgery. The number of beds used for urological patients had to be reduced to provide dedicated beds and personnel for the new COVID-19 wards. Also, there was a need to not infect elective patients via hospital contamination. Most importantly, from a urological perspective, most of the residual urological medical staff became entirely dedicated to managing the infected patients on the newly formed COVID-19 ward. Hence, the growing COVID-19 patient pool and lesser number of elective surgeries impacted the market in 2020.

Urolithiasis is a common urologic problem, and it poses a significant burden on the healthcare system globally. It is associated with an increased risk of end-stage renal failure, which is driving the demand for lithotripsy devices. As per the European Association of Urology, in 2019, the prevalence rates for urinary stones varied from 1% to 20%. In countries with a high standard of life, such as Canada, Sweden, or the US, renal stone prevalence is notably high (> 10%). For some areas, an increase of more than 37% has been reported over the last 20 years. It has been associated with an increased risk of end-stage renal failure. Thus, the increasing global prevalence of urolithiasis necessitates safe, efficacious, and affordable treatment for urolithiasis.

Over the years, lithotripsy has become the most preferred method for the treatment of kidney stones, mainly due to the advantage of its relative safety, low cost, less recovery time, and positive patient outcomes. Thus, all these factors are responsible for driving the market's growth.

However, apart from the several advantages, there are several risks associated with the lithotripsy treatment. This treatment sometimes leads to internal bleeding and may need a blood transfusion. It can lead to adverse side effects, where the kidney may get damaged due to blockage in the urine flow passage caused by tiny stone particles. There are complications, such as high blood pressure, which also restrain the market. Also, the adverse effects of lithotripsy shock waves often result in hypertension, diabetes, and, in some cases, permanent loss of functional renal volume, which act as major barriers for the lithotripsy devices market.

Lithotripsy Device Market Trends

Extracorporeal Shock Wave Lithotripsy (ESWL) Devices Segment Expected to Have a Significant Market Share

Extracorporeal shock wave lithotripsy is a technique for treating stones in the kidney and ureter that does not require surgery. Instead, high-energy shock waves are passed through the body and used to break stones into pieces as small as grains of sand. The extracorporeal shock wave lithotripsy devices (ESWL) are used for the treatment of kidney and ureter stones. This technology has been utilized by physicians worldwide and is expected to increase its penetration over the coming years due to the advantages offered, such as minimal invasiveness, reduced pain, shorter hospital stay, and quicker recovery time.

With the growing cases of COVID-19, fewer urology surgeries are being performed, which has also reduced the number of extracorporeal shock wave lithotripsy (ESWL) devices during this time, which is anticipated to have a slight negative impact on the market.

It is the most common lithotripsy performed outside the body. During extracorporeal shock wave lithotripsy (ESWL), a special machine known as lithotripter generates high-energy shock waves such as sound waves, x-rays, or ultrasound, which pass through the body until they hit the kidney stones.

ESWL was first performed in the US. However, it has been reported that some patients may not experience a successful outcome following ESWL. ESWL is only used in selected stones in the kidney and ureter. Therefore, it does not apply to all stone types or locations. Generally, this procedure is considered safe and less time-consuming as it takes only 45 minutes to perform. The growing demand for non-invasive procedures is leading to the adoption of ESWL.

Hence, the increasing number of kidney-related disorders, coupled with rising awareness across the globe, are likely to augment the market growth over the forecast period.

North America Holds the Largest Share of the Lithotripsy Device Market

In North America, the lithotripsy devices market is projected to witness growth over the forecast period. Chronic kidney diseases are estimated to be more common in women than men. The number of chronic kidney diseases is found to be increasing globally. Kidney disease statistics for the US convey the burden of chronic kidney disease (CKD) and end-stage renal disease (ESRD).

The COVID-19 pandemic has had a negative impact on the lithotripsy devices market due to the reduced number of surgeries being performed, resulting in reduced usage of the devices. The pandemic also affected the market by directly affecting production and demand by creating supply chain and market disruptions and financially impacting firms and financial markets negatively.

According to the Centers for Disease Control and Prevention, in 2019, around 37 million people, i.e., 1 out of every 7, or 15% of the adult population, were estimated to have chronic kidney diseases. With the increasing cases of kidney diseases, over 50,000 lithotripsy procedures are completed annually in the US, which helps in driving the lithotripsy devices market.

In January 2019, Shockwave Medical launched a US pivotal trial for its coronary lithotripsy device, designed to prepare heavily calcified coronary lesions for stenting. This technology uses sonic pressure waves to fracture intimal and medial calcium without damaging arterial tissue, which is likely to expand the company's business and help in driving the lithotripsy devices market in the country.

Hence, during the forecast period, the region's share of the global market is likely to grow significantly, owing to the high prevalence and the treatments of kidney stone disease in the US. Also, product launches, acquisitions, and collaborations are expected to promote the regional market.

Lithotripsy Device Market Competitor Analysis

The lithotripsy device market is competitive. The key market players operating in lithotripsy devices are EDAP TMS, Boston Scientific Corporation, Olympus Corporation, Accuron, and DirexGroup, among others. The companies are implementing certain strategic initiatives, such as mergers, new product launches, acquisitions, and partnerships, which help them strengthen their market positions. Furthermore, companies are also focusing on increasing the applications of lithotripsy devices to strengthen their positions over the forecast period.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Burden of Urolithiasis
    • 4.2.2 Rise in Number of Extracorporeal Shock Wave Lithotripsy Procedures
    • 4.2.3 Technological Advancements in Minimally Invasive Surgeries
  • 4.3 Market Restraints
    • 4.3.1 Adverse Effects Associated with Lithotripsy
    • 4.3.2 Availability of Alternative Treatments for Stone Removal
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Type
    • 5.1.1 Extracorporeal Shock Wave Lithotripsy Devices
    • 5.1.2 Intracorporeal Lithotripsy Devices
      • 5.1.2.1 Laser Lithotripsy Devices
      • 5.1.2.2 Electrohydraulic Lithotripsy Devices
      • 5.1.2.3 Ultrasonic Lithotripsy Devices
      • 5.1.2.4 Pneumatic (Ballistic) Lithotripsy Devices
  • 5.2 By Application
    • 5.2.1 Kidney Stones
    • 5.2.2 Ureteral Stones
    • 5.2.3 Pancreatic Stones
    • 5.2.4 Bile Duct Stones
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory Surgical Centers
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 US
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 UK
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 EDAP TMS
    • 6.1.2 Electro Medical Systems SA (Boston Scientific Corporation)
    • 6.1.3 Olympus Americas
    • 6.1.4 Dornier MedTech
    • 6.1.5 Becton, Dickinson, and Company
    • 6.1.6 Storz Medical AG
    • 6.1.7 Cook Medical LLC
    • 6.1.8 Walz Elektronik GmbH
    • 6.1.9 Novamedtek
    • 6.1.10 Elmed Medical Systems
    • 6.1.11 Karl Storz SE & Co. KG
    • 6.1.12 Siemens Healthineers AG
    • 6.1.13 Richard Wolf GmbH
    • 6.1.14 DirexGroup
    • 6.1.15 Lumenis

7 MARKET OPPORTUNITIES AND FUTURE TRENDS